Modern cancer pain management

Join us for a hybrid event providing an up-to-date view on current best practice in the cancer pain field.

Advances in cancer treatments mean that more people are living longer, even with incurable disease. This has uncovered a need to review our approach to cancer pain management, ensuring that care is more personalised, and consistent with stage of disease. This course brings together expertise in the cancer pain field to provide an up to date view on current best practice.

Monday 30 September 2024, 9am to 5pm BST

What to expect

Latest evidence on management of cancer pain at different stages of the disease
The pitfalls of high doses of opioid
NSAIDS and COX-II inhibitors
Newer approaches including personalised cancer pain assessment
Supportive oncology – the new kid on the block

Intended audience

GPs, community palliative care services, community pharmacists.

Prices

Early bird: virtual and on-demand: £65
Early bird on-site delegate (including lunch): £65
Onsite/virtual: offer 5 for 4: £64 per ticket
Student/charity (virtual/on-demand): £50
Low and middle-income countries (LMIC) (virtual/on-demand): £40
Pharma and industry (virtual/on-demand): £150

Once early bird finishes

Virtual and on-demand: £80
On-site delegate (including lunch): £80

All tickets (on-site and virtual) include access to the event recordings, resources and presentations for up to 6 months post-event date.

Sponsors

Silver sponsor

Cancer pain management for community teams - Monday 30 September 2024

Time	Session
9.15	Registration
9.30	Welcome
9.40	How is Cancer care changing and how to provide care consistent with stage of disease? Dr Richard Berman, Consultant supportive care and palliative medicine, The Christie NHS Foundation Trust
10.00	Some interesting cases/patient stories: Why cancer pain management needs a re-think? Karen Anthony, Palliative care nurse, The Christie NHS Foundation Trust Sarah Beckett, Clinical nurse specialist, The Christie NHS Foundation Trust Liz Elliot, Clinical cytogeneticist, The Christie NHS Foundation Trust
10.20	Use of opioids in cancer pain (including hyperalgesia, narcotic bowel syndrome, long-term effects of opioids) Dr Ash Ahamed, Consultant supportive care and palliative medicine, The Christie NHS Foundation Trust

11.00 - break

Time	Session
11.15	The return of diamorphine? Carole Mula, Palliative care nurse specialist, The Christie NHS Foundation Trust
11.35	NSAIDs and COX-II Inhibitors (Including risks/concurrent prescribing/what to look out for/guidelines) Jo Collins, Lead supportive and oncology pharmacist, The Christie NHS Foundation Trust
11.55	Neuropathic agents (when to use, which to use, what to look out for) Ollie Williams, Specialist clinical pharmacist, IP supportive care and onoclogy (colorectal), The Christie NHS Foundation Trust

12.35 - lunch

Time	Session
13.15	Cancer breakthrough pain (which to use, what dose, what to look out for) Mark Warren , Operational lead and Macmillan clinical nurse specialist, The Christie NHS Foundation Trust Jason Simons, Supportive care clinical nurse specialist, The Christie NHS Foundation Trust
13.35	Managing cancer pain in renal or hepatic impairment (which to use, what dose, what to look out for) Emma Moohan, Supportive care pharmacist, The Christie NHS Foundation Trust
13.55	A new approach to cancer pain management Dr Emma Kellet, Consultant in Palliative Medicine, Countess of Chester NHS Foundation Trust

14.35 - break

Time	Session
14.50	Non-pharmacological approaches Nic Chesman, Macmillan senior physiotherapist, The Christie NHS Foundation Trust
15.10	Low-dose opioid therapy in the inpatient palliative care setting, including for end-of-life care Dr Victoria Hedges, Consultant in palliative medicine, Oxford University Hospitals NHS Foundation Trust
15.30	Questions and answers

16.00 - close

Education events sponsorship opportunities

If you are interested in sponsorship opportunities, see how you can support the development of cancer education and patient care.